E. Sabrià

Use of the sFlt-1/PlGF ratio to rule out preeclampsia requiring delivery in women with suspected disease. Is the evidence reproducible?

P. Lequerica-Fernández, E. Martínez-Morillo, F. V. Álvarez, 2017, Clinical chemistry and laboratory medicine.

Development of a Third Trimester Contingent Prognostic Prediction Scheme for Suspected Early-Onset Pre-Eclampsia

C. Barceló-Vidal, P. Lequerica-Fernández, E. Martínez-Morillo, 2021, Fetal Diagnosis and Therapy.

Addition of N‐terminal pro‐B natriuretic peptide to soluble fms‐like tyrosine kinase‐1/placental growth factor ratio > 38 improves prediction of pre‐eclampsia requiring delivery within 1 week: a longitudinal cohort study

P. Lequerica-Fernández, E. Martínez-Morillo, F. V. Álvarez, 2018, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

Robotic Transperitoneal Infrarenal Para-Aortic Lymphadenectomy With Double Docking: Technique, Learning Curve, and Perioperative Outcomes.

E. Sabrià, L. Martí, J. Ponce, 2016, Journal of minimally invasive gynecology.

A new model for screening for early-onset preeclampsia.

Elena Carreras, Ignacio Rodríguez, E. Carreras, 2020, American journal of obstetrics and gynecology.

A more accurate prediction to rule in and rule out pre-eclampsia using the sFlt-1/PlGF ratio and NT-proBNP as biomarkers

P. Lequerica-Fernández, E. Martínez-Morillo, M. Martínez-Triguero, 2019, Clinical chemistry and laboratory medicine.

P07.17: The use of first trimester biochemical markers for crown‐rump length quality control

E. Sabrià, A. Borrell, J. Sabria, 2012 .